Kuwait diabetes long-term follow-up study
Part of Digestive system, Hormones & metabolism, Immune system & allergy clinical trials.
This study checks in on people with prediabetes or type 2 diabetes who were part of an earlier Kuwait diabetes study. It aims to understand how their condition has changed and what health care they may need.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You previously took part in the Kuwait Diabetes Epidemiologic Study (KDEP).
- You have prediabetes or type 2 diabetes.
- You are not pregnant.
- You are willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a ketogenic diet can help people with prediabetes or high blood sugar improve their health and lose weight. You eat very low-carb, high-fat foods to see if it lowers your blood sugar and reduces your risk of developing diabetes.
This study compares two versions of a ketogenic (very low-carb) diet to see how they affect blood sugar control and inflammation. It may help people with overweight or obesity who have pre-diabetes-level blood sugar understand which fat sources work better.
This study follows up with people who took part in an earlier diabetes study (PrévenDIAB) to see how their health has changed over three years, focusing on diabetes risk and early aging related to income and education. It may help understand how social factors affect health.
This study looks at people with type 2 diabetes who also have fatty liver. The goal is to learn more about this condition in a Saudi group and test approaches that could improve care.
This study looks at how people with diabetic kidney disease engage with their care. It may help find ways to better support patients, though it does not test a new treatment.
This study looks at health changes and complications in people with type 1 or type 2 diabetes, or prediabetes. It may help researchers better understand risk factors over time and how to improve care.
Hear when a new NAFLD (Nonalcoholic Fatty Liver Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.